Maximilian von Eynatten

15.9k citations
118 papers · 11.1k · 7 hit papers · h-index 44

Impact in

Papers in

Maximilian von Eynatten

111 papers receiving 10.9k citations

Maximilian von Eynatten's Hit Papers

Effect of Linagliptin vs Glimepiride on Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes 2019 · 410 citations
4100+7+15Years since publication50010001.5k2.0k2.5k

Peers

Maximilian von Eynatten
Comparison fields: 5 of 125
  • Endocrinology, Diabetes and Metabolism 7.3k
  • Nephrology 1.5k
  • Biological Psychiatry 269
  • Behavioral Neuroscience 295
  • Surgery 2.2k
Replace Scott C. Thomson with:
Scott C. Thomson United States
Samuel Dagogo‐Jack United States
Adam Whaley‐Connell United States
Leena Mykkänen Finland
Joël Ménard France
Fritz R. Bühler Switzerland
Frej Fyhrquist Finland
Nicholas Emanuele United States
Guntram Schernthaner Austria
Joshua I. Barzilay United States
Maximilian von Eynatten relative to Scott C. Thomson United States Scott C. Thomson's profile →
Citations per field
00.5×8.4×
Scott C. Thomson · 1×
Citations per year

Countries citing papers authored by Maximilian von Eynatten

Since Specialization
Citations

This map shows the geographic impact of Maximilian von Eynatten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maximilian von Eynatten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maximilian von Eynatten more than expected).

Fields of papers citing papers by Maximilian von Eynatten

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maximilian von Eynatten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maximilian von Eynatten. The network helps show where Maximilian von Eynatten may publish in the future.

Co-authors

The 25 scholars most cited alongside Maximilian von Eynatten, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Maximilian von Eynatten Line = papers co-authored together Maximilian von Eynatten links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 118 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
Hit paper breakdown →
20162624
2
Renal Hemodynamic Effect of Sodium-Glucose Cotransporter 2 Inhibition in Patients With Type 1 Diabetes Mellitus
Hit paper breakdown →
2013988
3
Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk
Hit paper breakdown →
2018774
4
A mechanism converting psychosocial stress into mononuclear cell activation
Hit paper breakdown →
2003695
5
Effect of Linagliptin vs Glimepiride on Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes
Hit paper breakdown →
2019410
6
The effect of empagliflozin on arterial stiffness and heart rate variability in subjects with uncomplicated type 1 diabetes mellitus
Hit paper breakdown →
2014383
7
Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease
Hit paper breakdown →
2017351
8 2017294
9 2012278
10 2013245
11 2012192
12 2012167
13 2018160
14 2016149
15 2020146
16 2007146
17 2018145
18 2013140
19 2012126
20 2006116

About Maximilian von Eynatten

Maximilian von Eynatten is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery, Epidemiology, Molecular Biology and Nephrology, having authored 118 papers that have together received 11.1k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (70 papers), Adipokines, Inflammation, and Metabolic Diseases (13 papers), Pancreatic function and diabetes (10 papers), Chronic Kidney Disease and Diabetes (8 papers), Adipose Tissue and Metabolism (5 papers), Diabetes Management and Research (5 papers), Diet and metabolism studies (5 papers) and Metabolism, Diabetes, and Cancer (4 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (7.3k citations), Nephrology (1.5k citations), Biological Psychiatry (269 citations), Behavioral Neuroscience (295 citations) and Surgery (2.2k citations). Maximilian von Eynatten has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Odd Erik Johansen, Hans J. Woerle, Christoph Wanner, Bernard Zinman, Uli C. Broedl, Michaela Mattheus, Silvio E. Inzucchi, John M. Lachin, David Fitchett and Hans‐Juergen Woerle. Their work appears in journals such as Diabetes Obesity and Metabolism, Diabetes Care, Nephrology Dialysis Transplantation, Diabetes and Cardiovascular Diabetology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact